13D/13G Filings - Choo Chee Kong

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-14
7:09 pm
Sale
2025-02-2013DCytoMed Therapeutics Limited
GDTC
Choo Chee Kong3,773,291
23.170%
-715,000decrease
(-15.93%)
Filing
History
2024-05-23
06:10 am
Sale
2024-05-2313GCytoMed Therapeutics Limited
GDTC
Choo Chee Kong4,488,291
38.890%
-165,313decrease
(-3.55%)
Filing
History
2024-02-14
4:00 pm
Unchanged
2024-02-1413GCytoMed Therapeutics Limited
GDTC
Choo Chee Kong4,653,604
40.300%
0
(Unchanged)
Filing
History
2023-04-21
3:16 pm
Purchase
2023-04-1413DCytoMed Therapeutics Limited
GDTC
Choo Chee Kong4,653,604
42.540%
4,653,604increase
(New Position)
Filing
History